Sr. Capability Manager, Data & Analytics at Legend Biotech

Franklin Township, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

B.S. Degree
At least 8 years of experience in business intelligence, analytics, or data strategy, with 3+ years in a similar role

Responsibilities

Act as the main business partner for data and analytics needs, working closely with Supply Chain, Manufacturing, Commercial, Corporate, and BCMA
Partner with the SAP COE and Technical Services Data team to ensure business priorities are understood, translated, and delivered in line with enterprise standards
Coordinate with JV IT teams and CMOs on data ingestion and sharing, ensuring accuracy, compliance, and business alignment
Help the business use consistent KPIs and reporting frameworks, reducing duplicate or conflicting reports and driving a “single source of truth.”
Represent Data & Analytics Enablement in IT working groups, governance committees, and SteerCo forums, ensuring the business perspective is well represented
Keep stakeholders updated on progress, risks, and outcomes across analytics initiatives, ensuring transparency and accountability
Support GMS leadership by tracking and prioritizing their analytics and reporting needs
Facilitate prioritization of analytics initiatives across functions, balancing urgent needs with long-term enterprise goals
Monitor adoption and value realization of analytics solutions, sharing outcomes with business leaders and steering groups
Provide input into the enterprise data and analytics roadmap, ensuring it reflects evolving business needs and regulatory requirements
Build strong partnerships across IT and the business to foster a culture of data-driven decision making

Skills

Data Analytics

Reporting

KPIs

Data Lake

SAP

Business Intelligence

Data Ingestion

Stakeholder Management

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free